● Covered by 1 source · 1 reportMedium impact1 positive
Tiny Health Secures $33M in Series B Funding for Microbiome Testing Platform
Key points
- Tiny Health raised $33 million in Series B funding.
- B Capital led the funding round, with Nick Whitehead joining the board.
- Total funding for Tiny Health now stands at $46 million.
- The company offers at-home microbiome tests for babies and adults.
Funding Announcement
Tiny Health, an Austin-based company, announced it has secured $33 million in a Series B funding round. B Capital led this latest investment, bringing Tiny Health's total funding to $46 million. Nick Whitehead from B Capital will join the company's board of directors.
Company Background and Growth
Founded in 2020 by Cheryl Sew Hoy, Tiny Health developed its platform over two years before launching an at-home baby gut test in 2022. The company's revenue has more than doubled annually, and its B2B arm, Powered by Tiny, saw a fourfold increase in growth last year. Tiny Health's offerings have expanded from baby gut tests to include adult, pregnancy, and vaginal microbiome testing.
Market Demand and Impact
The demand for Tiny Health's at-home microbiome tests is growing, driven by parents seeking more information about conditions like eczema in infants and clinicians looking for practical tools to apply microbiome research. The company's platform aims to provide insights into how microbial exposure can influence health outcomes, particularly in early life.
✨ This summary was generated by AI from the outlets' reporting listed below. It is not independently verified and may contain errors — check the original sources. How BrevFeed works →
The daily brief
One email each morning: the day's tech stories, clustered across outlets and summarized. No account needed.
One email a day. Unsubscribe in one click, any time.
Today's brief
Spend a few minutes, get the whole day. Every topic's top stories in one hands-free rundown — listen, watch, or read the transcript.
▶ Play today's brief
New every morning, and the back catalogue is archived by date.
Reporting from
Tiny Health, a company specializing in at-home microbiome testing, raised $33 million in a Series B funding round. This funding will support the expansion of its platform, which analyzes gut data to provide insights into health, particularly for infants and pregnant individuals.